Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Makena Resources Inc
CANSF | US
0.12
USD0
0%
CANSF | US
Loading StockChartView...
About Makena Resources Inc
Sector
Basic Materials
Industry
Industrial Metals & Minerals
Earnings date
30/06/2024
As of date
20/04/2026
Close
0.12
Open
0.12
High
0.12
Low
0.12
Willow Biosciences Inc. a biotechnology company develops produces and sells plant derived ingredients for consumer care food and beverage and pharmaceutical product industries in Canada. Willow Biosciences Inc. is headquartered in Calgary Canada.
View LessCANSF | US
Risk
187.2
Sharpe
3.74
Luna's Score
51/100
Recommendation
Hold
Luna says (CANSF | US)
What's Working
Positive Momentum
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
187.2%1 month
187.2%3 months
160.2%6 months
125.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
67.11
Price to book
11.22
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-0.67
Ent. to rev.
8.47
PEG
-
Other Fundamentals
EBITDA
-8.08M
MarketCap
18.60M
MarketCap(USD)
18.60M
Div. yield
-
Op. margin
-140.94
Erngs. growth
-
Rev. growth
660.00
Ret. on equity
-212.20
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.02
Range1M
0.02
Range3M
0.02
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.14
Price X volume
122.20
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.67 | -1.43 | Expensive |
| Ent. to Revenue | 8.47 | 208.44 | Cheaper |
| PE Ratio | - | 47.94 | - |
| Price to Book | 11.22 | 3.33 | Expensive |
| Dividend Yield | - | 2.40 | - |
| Std. Deviation (3M) | 160.16 | 74.41 | Riskier |
| Debt to Equity | - | 0.51 | - |
| Debt to Assets | - | 0.18 | - |
| Market Cap | 18.60M | 9.26B | Emerging |
